| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 01/02/2003 | US20030003163 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 01/02/2003 | US20030003162 Administering a vitamin (ascorbic acid), an amino acid (arginine) and a trace element (magnesium) for treatment of high blood pressure, asthma, glaucoma and tinnitus |
| 01/02/2003 | US20030003095 Activated carbon for preventing pregnancy and sexually transmitted disease |
| 01/02/2003 | US20030003094 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 01/02/2003 | US20030003056 Useful in in vivo applications sucha as embolizing blood vessels and/or reversibly sterilizing mammals |
| 01/02/2003 | EP1270580A1 Antimicrobial acesulfame complexes, their preparation and their use |
| 01/02/2003 | EP1270009A1 Antiviral agent containing a combination of calcium salts of organic (fish and shells) and of mineral source |
| 01/02/2003 | EP1270001A1 Pharmaceutical composition containing calcium acetate and calcium carbonate |
| 01/02/2003 | EP1269988A1 Cosmetic or dermatological composition comprising acylaminoamide derivatives |
| 01/02/2003 | EP1268854A1 High specificity marker detection |
| 01/02/2003 | EP1268844A1 Modulating production of pneumococcal capsular polysaccharide |
| 01/02/2003 | EP1267946A2 Nanocapsule encapsulation system and method |
| 01/02/2003 | EP1267933A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 01/02/2003 | EP1267896A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
| 01/02/2003 | EP1267895A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 01/02/2003 | EP1267890A2 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity |
| 01/02/2003 | EP1267888A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 01/02/2003 | EP1267851A2 Method and compositions for preventing hormone induced adverse effects |
| 01/02/2003 | EP1267837A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1267816A1 The use of xanthan gum for gelling cio 2 and related species |
| 01/02/2003 | EP1267800A1 Methods of modulating hair growth |
| 01/02/2003 | EP1267796A1 Foamable dental fluoride composition |
| 01/02/2003 | EP1267616A1 Methods of modulating hair growth |
| 01/02/2003 | EP0928195B1 Compositions for use in embolizing blood vessels |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/01/2003 | CN1387905A Orally taken fracture setting Chinese medicine |
| 01/01/2003 | CN1387899A Externally applied ointment for treating burns and its prepn |
| 01/01/2003 | CN1387896A Compound seabuckthorn fruit oil suppository |
| 01/01/2003 | CN1387892A Medicine tablet for treating acute and chronic cholecytitis and cholelithiais and its prepn process |
| 01/01/2003 | CN1387886A Chinese medicine prepn for treating lupus erythematosus |
| 01/01/2003 | CN1387859A Antilipemic Chinese medicine capsule |
| 01/01/2003 | CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy |
| 12/31/2002 | US6500868 Method for preventing and treating peripheral neuropathy by administering selegiline |
| 12/31/2002 | US6500808 Anti-viral composition |
| 12/31/2002 | US6500458 Condensate of SAR abolisher, producing method thereof, and SAR abolisher powder |
| 12/31/2002 | US6500452 Mixture of aminobenzoic acid, hydroxybenzoic acid, cysteine, methionine, selenium, lithium bromide and plant extracts |
| 12/31/2002 | US6500450 Composition for treating migraine headaches |
| 12/31/2002 | US6500183 Microdermabrasion device |
| 12/31/2002 | CA2281673C Methods for administering nutritional indium |
| 12/28/2002 | CA2351805A1 A method of manufacturing a pill medicine for killing spirilla |
| 12/27/2002 | WO2002103055A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION |
| 12/27/2002 | WO2002102394A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | WO2002102393A1 Composition for treating varicosity and method of preparation thereof |
| 12/27/2002 | WO2002102352A1 Composition for the treatment of diseases which affect animals' hooves |
| 12/27/2002 | WO2002005851A8 Enhancement of the action of central and peripheral nervous system agents |
| 12/27/2002 | CA2449898A1 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/26/2002 | US20020198567 Electro-endocytotic therapy as a treatment modality of cancer |
| 12/26/2002 | US20020198153 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent |
| 12/26/2002 | US20020198137 Antineoplastic combinations |
| 12/26/2002 | US20020197609 Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| 12/26/2002 | US20020197335 Antioxidants in clusters of structured water |
| 12/26/2002 | US20020197334 Pharmaceutical composition for the treatment of diabetes mellitus |
| 12/26/2002 | US20020197333 DASC compositions, process for preparing same and suspensions containing same |
| 12/26/2002 | US20020197332 Treatment for ectoparasites |
| 12/26/2002 | US20020197331 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 12/26/2002 | US20020197330 Method of dietary supplementation |
| 12/26/2002 | US20020197313 Unit dosage forms for the treatment of herpes simplex |
| 12/26/2002 | US20020197245 Antitumour compositions containing taxane derivatives |
| 12/26/2002 | US20020197207 Radionuclide-coated particulate material |
| 12/26/2002 | CA2391580A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one antifungal agent or at least one antibacterial agent |
| 12/25/2002 | CN1387441A Use of nitric oxide for treatment of airway constriction |
| 12/25/2002 | CN1387438A 联合化学疗法 Combined chemotherapy |
| 12/25/2002 | CN1387419A Microdermabrasion device |
| 12/25/2002 | CN1386540A Medicine for treating mastropathy by exteriorly applying to acupoints |
| 12/25/2002 | CN1386513A Ointment for treating burn and scald and its preparing process |
| 12/25/2002 | CN1096868C Medical paste for treating cancer |
| 12/25/2002 | CN1096856C Method for topical treatment of scar tissue and related tissue reaction to trauma |
| 12/24/2002 | US6498181 Enhancing humoral immune response in combination with cancer therapy including surgery, radiation and immunotherapy |
| 12/24/2002 | US6497901 Calcium sulfate |
| 12/24/2002 | US6497885 Combination of the herb vitex agnus-castus (chasteberry) and antioxidants, including green tea, vitamin e or selenium, l-arginine, folic acid, vitamins b6 and b12, iron, zinc and magnesium; promoting ovulation |
| 12/19/2002 | WO2002100444A1 Colloidal metal labelled microparticles, their production and use |
| 12/19/2002 | WO2002100422A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 12/19/2002 | WO2002100421A1 Low molecular weight components of cartilage, complexes of copper with amino acids or di-peptides; processes for preparation and therapeutic uses thereof |
| 12/19/2002 | WO2002100420A2 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne |
| 12/19/2002 | WO2002100419A1 Use of a phosphate adsorbent to combat vascular diseases |
| 12/19/2002 | WO2002100418A1 Exothermic formulations for the treatment of ectoparasites |
| 12/19/2002 | WO2002100395A1 Bismuth salts of anti-oxidants and radical scavengers for prevention and treatment of mucous membrane ulcers |
| 12/19/2002 | WO2002100391A1 Swallow tablet comprising paracetamol |
| 12/19/2002 | WO2002100383A1 Porous sponge-like cellulosic material for treatment of injuries |
| 12/19/2002 | WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 12/19/2002 | WO2002100329A2 Methods and compositions for helping the body resist the effects of the aging process |
| 12/19/2002 | WO2002080754A3 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 12/19/2002 | WO2002076388A3 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside |
| 12/19/2002 | WO2002065981A3 Chemotherapeutic composition using calcium phosphate paste |
| 12/19/2002 | WO2002038500A3 Process for the rehydration of magaldrate powder |
| 12/19/2002 | WO2002005795A3 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 12/19/2002 | US20020193855 Patient temperature regulation method and apparatus |
| 12/19/2002 | US20020193434 Stilbene derivative and a platinum coordination compound |
| 12/19/2002 | US20020193416 Synergistic tumorcidal response induced by histamine |
| 12/19/2002 | US20020193391 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| 12/19/2002 | US20020193362 Anti-tumor composition |
| 12/19/2002 | US20020193355 For therapy and prophylaxis of osteoporosis |
| 12/19/2002 | US20020193344 Acid controlled induced viscosity fiber system and uses thereof |
| 12/19/2002 | US20020193339 Antiviral agent for use in treatment of cancer |
| 12/19/2002 | US20020193321 Shelf life |
| 12/19/2002 | US20020192308 Method and composition for controlling weight |
| 12/19/2002 | US20020192303 Treatment of side effects associated with alcohol consumption |
| 12/19/2002 | US20020192298 Treatment of acne |
| 12/19/2002 | US20020192297 Hydrogen peroxide disinfectant with increased activity |